| __timestamp | Bausch Health Companies Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 7180000000 |
| Thursday, January 1, 2015 | 582800000 | 6704000000 |
| Friday, January 1, 2016 | 455000000 | 7194000000 |
| Sunday, January 1, 2017 | 366000000 | 9982000000 |
| Monday, January 1, 2018 | 414000000 | 9752000000 |
| Tuesday, January 1, 2019 | 471000000 | 9872000000 |
| Wednesday, January 1, 2020 | 452000000 | 13397000000 |
| Friday, January 1, 2021 | 465000000 | 12245000000 |
| Saturday, January 1, 2022 | 529000000 | 13548000000 |
| Sunday, January 1, 2023 | 604000000 | 30531000000 |
Infusing magic into the data realm
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Merck & Co., Inc. and Bausch Health Companies Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking in 2023 with a staggering $30.5 billion, reflecting its commitment to groundbreaking medical advancements. In contrast, Bausch Health's R&D spending remained relatively stable, with a modest increase of approximately 145% over the same period, reaching $604 million in 2023. This disparity highlights Merck's aggressive pursuit of innovation compared to Bausch Health's more conservative strategy. As the pharmaceutical landscape continues to shift, these investment patterns offer a glimpse into the future of healthcare innovation.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Insights: How Merck & Co., Inc. and Zoetis Inc. Allocate Funds
Merck & Co., Inc. vs Biogen Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Merck & Co., Inc. and Incyte Corporation
R&D Spending Showdown: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Merck & Co., Inc. vs Travere Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Merck & Co., Inc. or MiMedx Group, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Viridian Therapeutics, Inc.